Show simple item record

dc.contributor.authorNieto Jiménez, Celia 
dc.contributor.authorVega Moreno, Milena Amparo 
dc.contributor.authorMarcelo, Gema
dc.contributor.authorMartín del Valle, Eva María 
dc.date.accessioned2026-01-26T08:50:38Z
dc.date.available2026-01-26T08:50:38Z
dc.date.issued2018-10-08
dc.identifier.citationNieto, C., Vega, M.A., Marcelo, G., Martín del Valle, E.M. (2018). Polydopamine nanoparticles kill cancer cells. RSC Adv., 8, 36201.es_ES
dc.identifier.urihttp://hdl.handle.net/10366/169278
dc.description.abstract[EN]Polydopamine (PD) is a synthetic melanin analogue of growing importance in the eld of biomedicine, especially with respect to cancer research, due, in part, to its biocompatibility. But little is known about the cytotoxic e ects of PD on cancer cell lines. PD is a UV-vis absorbing material whose absorbance overlaps with that of formazan salts, which are used to assess cell viability in MTT assays. In this study, a protocol has been established to eliminate the contributing absorbance of PD at 550 nm, and has been applied to characterize the cytotoxicity of PD nanoparticles in both healthy and breast cancer cell lines. Once the protocol is applied, it was found that PD is per se an antineoplastic system, meaning it selectively kills cancer cells, especially those of breast cancer, but it has no toxic effect on healthy cells. The mechanism of action could be related to the production of ROS and the alteration of iron homeostasis in lysosomes. To the best of our knowledge there are only a few examples of nanoparticle systems devoid of drugs that selectively kill cancer cells.es_ES
dc.description.sponsorshipJunta de Castilla y Leónes_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherRoyal Society of Chemistryes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPolidopaminaes_ES
dc.subjectNanopartículases_ES
dc.subjectSistemas transportadoreses_ES
dc.subjectNanomedicinaes_ES
dc.subject.meshNanomedicine *
dc.subject.meshNanoparticles *
dc.titlePolydopamine nanoparticles kill cancer cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttp://dx.doi.org/10.1039/C8RA05586Fes_ES
dc.subject.unesco3312 Tecnología de Materialeses_ES
dc.subject.unesco3303 Ingeniería y Tecnología Químicases_ES
dc.identifier.doi10.1039/c8ra05586f
dc.relation.projectIDSA004U16es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn2046-2069
dc.journal.titleRSC Advanceses_ES
dc.volume.number8es_ES
dc.issue.number63es_ES
dc.page.initial36201es_ES
dc.page.final36208es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsnanopartículas *
dc.subject.decsnanomedicina *


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional